The Swedish Competition Authority moves its investigation of Oriola’s sale of Svensk dos AB to Apotekstjänst Sverige AB into phase II
Oriola Corporation Stock Exchange Release 31 January 2024 at 9:00 a.m. EET
The Swedish Competition Authority moves its investigation of Oriola’s sale of Svensk dos AB to Apotekstjänst Sverige AB into phase II
The Swedish Competition Authority (Konkurrensverket) moves its investigation of Oriola’s sale of Svensk dos AB to Apotekstjänst Sverige AB into phase II.
Oriola announced on 13 October 2023 the sale of all shares in Svensk dos AB to Apotekstjänst Sverige AB. In addition, Oriola communicated that it had not identified a recovery of the business within the foreseeable future, due to the prevailing tender market structure and dynamics. For this reason, Oriola has decided to exit the dose dispensing business.
Oriola expects, based on currently available information, that the transaction will be completed in the second quarter of 2024.
Due to the silent period ahead of the publication of Oriola’s Financial Statements Release 2023 on Friday 16 February 2024, Oriola will not provide further comments on this topic.
Oriola Corporation
Distribution:
Nasdaq Helsinki Ltd.
Key media
